The rise of Viagra initially sparked a surge for the drug industry, but recent changes present a uncertain picture for shareholders. Generic alternatives are eroding earnings, and continued litigation add additional https://zakariawgnl338010.ourcodeblog.com/41575959/the-blue-pill-and-big-pharma-a-precarious-investment